Gene description for DRD4 |
| Gene name |
dopamine receptor D4 |
| Gene symbol |
DRD4 |
| Other names/aliases |
D4DR |
| Species |
Homo sapiens |
Experiment description of studies that identified DRD4 in Serum |
| 1
|
| Experiment ID | 440 |
| Identified molecule | mRNA
|
| Extracellular vesicle type | Exosomes/Microvesicles |
| MISEV | EVs |
| Identification method | Microarray
|
| PubMed ID |
22251860
|
| Organism | Homo sapiens |
| Experiment description | RNA expression patterns in serum microvesicles from patients with glioblastoma multiforme and controls. |
| Authors | Noerholm M, Balaj L, Limperg T, Salehi A, Zhu LD, Hochberg FH, Breakefield XO, Carter BS, Skog J. |
| Journal name |
BMC Cancer
|
| Publication year | 2012 |
| Sample | Serum |
| Sample name | Normal-Serum |
| Isolation/purification methods | - |
| Flotation density | - |
| Molecules identified in the study | mRNA |
| Methods used in the study | Microarray |
| EV-TRACK |
EV120150: EV-METRIC:0%
|
|
|
| 2
|
| Experiment ID | 441 |
| Identified molecule | mRNA
|
| Extracellular vesicle type | Exosomes/Microvesicles |
| MISEV | EVs |
| Identification method | Microarray
|
| PubMed ID |
22251860
|
| Organism | Homo sapiens |
| Experiment description | RNA expression patterns in serum microvesicles from patients with glioblastoma multiforme and controls. |
| Authors | Noerholm M, Balaj L, Limperg T, Salehi A, Zhu LD, Hochberg FH, Breakefield XO, Carter BS, Skog J. |
| Journal name |
BMC Cancer
|
| Publication year | 2012 |
| Sample | Serum |
| Sample name | Patients of glioblastoma -Serum |
| Isolation/purification methods | - |
| Flotation density | - |
| Molecules identified in the study | mRNA |
| Methods used in the study | Microarray |
| EV-TRACK |
EV120150: EV-METRIC:0%
|
|
|
| 3
|
| Experiment ID | 978 |
| Identified molecule | protein
|
| Extracellular vesicle type | Exosomes |
| MISEV | EVs |
| Identification method | Mass spectrometry
|
| PubMed ID |
22808001
|
| Organism | Homo sapiens |
| Experiment description | Biochemical and physical characterisation of urinary nanovesicles following CHAPS treatment. |
| Authors | Musante L, Saraswat M, Duriez E, Byrne B, Ravidà , Domon B, Holthofer H. |
| Journal name |
PLoS One
|
| Publication year | 2012 |
| Sample | Serum |
| Sample name | Serum -Tuberculosis patient 8 |
| Isolation/purification methods | Filtration ExoQuick |
| Flotation density | - |
| Molecules identified in the study | Protein |
| Methods used in the study | Mass spectrometry |
| EV-TRACK |
EV120006: EV-METRIC:56%
|
|
|